FDA Recalls Blood Pressure Medications Nationwide

[мышка Машка]

Several blood pressure medications have been recalled by the FDA due to the potential presence of cancer-causing impurities. These recalls, primarily involving angiotensin II receptor blockers (ARBs), are voluntary actions by pharmaceutical companies. The FDA has been working with manufacturers to reduce and remove nitrosamines, a type of impurity, from these medications.
Medications Affected:
Valsartan: Recalled due to the presence of N-nitrosodimethylamine (NDMA).
Losartan: Recalled due to the presence of N-methylnitrosobutyric acid (NMBA), another potential carcinogen.
Irbesartan: Recalled due to the potential presence of N-nitrosoirbesartan impurity.
Combination drugs with valsartan, losartan, or irbesartan: Also recalled due to the presence of the above impurities.

И еще - In late June, the U.S. Food and Drug Administration (FDA) announced that 33,024 bottles of Metoprolol Succinate Extended-Release Tablets have been recalled nationwide. This recall applies to 100-count and 500-count bottles, both reportedly containing 25-milligram (mg) tablets and are available by prescription only.